These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32825480)

  • 21. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
    Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
    J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, X-ray structure and in vitro cytotoxicity studies of Cu(I/II) complexes of thiosemicarbazone: special emphasis on their interactions with DNA.
    Saswati ; Chakraborty A; Dash SP; Panda AK; Acharyya R; Biswas A; Mukhopadhyay S; Bhutia SK; Crochet A; Patil YP; Nethaji M; Dinda R
    Dalton Trans; 2015 Apr; 44(13):6140-57. PubMed ID: 25736331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure and biological evaluation of bis salicylaldehyde-4(N)-ethylthiosemicarbazone ruthenium(iii) triphenylphosphine.
    Prabhakaran R; Kalaivani P; Jayakumar R; Zeller M; Hunter AD; Renukadevi SV; Ramachandran E; Natarajan K
    Metallomics; 2011 Jan; 3(1):42-8. PubMed ID: 21132183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, characterization and biological activity of copper complexes with pyridoxal thiosemicarbazone derivatives. X-ray crystal structure of three dimeric complexes.
    Belicchi Ferrari M; Bisceglie F; Pelosi G; Tarasconi P; Albertini R; Dall'Aglio PP; Pinelli S; Bergamo A; Sava G
    J Inorg Biochem; 2004 Feb; 98(2):301-12. PubMed ID: 14729310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
    Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
    Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
    Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of terminal N-substitution in 2-oxo-1,2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the mode of coordination, structure, interaction with protein, radical scavenging and cytotoxic activity of copper(II) complexes.
    Raja DS; Paramaguru G; Bhuvanesh NS; Reibenspies JH; Renganathan R; Natarajan K
    Dalton Trans; 2011 May; 40(17):4548-59. PubMed ID: 21431149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action.
    Ohui K; Afanasenko E; Bacher F; Ting RLX; Zafar A; Blanco-Cabra N; Torrents E; Dömötör O; May NV; Darvasiova D; Enyedy ÉA; Popović-Bijelić A; Reynisson J; Rapta P; Babak MV; Pastorin G; Arion VB
    J Med Chem; 2019 Jan; 62(2):512-530. PubMed ID: 30507173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.
    Lovejoy DB; Sharp DM; Seebacher N; Obeidy P; Prichard T; Stefani C; Basha MT; Sharpe PC; Jansson PJ; Kalinowski DS; Bernhardt PV; Richardson DR
    J Med Chem; 2012 Aug; 55(16):7230-44. PubMed ID: 22861499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halo-substituted thiosemicarbazones and their copper(II), nickel(II) complexes: detailed spectroscopic characterization and study of antitumour activity against HepG2 human hepatoblastoma cells.
    Jagadeesh M; Kalangi SK; Sivarama Krishna L; Reddy AV
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():552-6. PubMed ID: 24084484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility,
    Bharathi S; Mahendiran D; Kumar RS; Kim YG; Gajendiran M; Kim K; Rahiman AK
    Chem Res Toxicol; 2019 Aug; 32(8):1554-1571. PubMed ID: 31241919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde.
    Leovac VM; Bogdanović GA; Jovanović LS; Joksović L; Marković V; Joksović MD; Denčić SM; Isaković A; Marković I; Heinemann FW; Trifunović S; Đalović I
    J Inorg Biochem; 2011 Nov; 105(11):1413-21. PubMed ID: 21955843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of polar substituents on the biological activity of thiosemicarbazone metal complexes.
    Bisceglie F; Tavone M; Mussi F; Azzoni S; Montalbano S; Franzoni S; Tarasconi P; Buschini A; Pelosi G
    J Inorg Biochem; 2018 Feb; 179():60-70. PubMed ID: 29175629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Characterization and Biological Activity of Novel Cu(II) Complexes of 6-Methyl-2-Oxo-1,2-Dihydroquinoline-3-Carbaldehyde-4n-Substituted Thiosemicarbazones.
    Ramachandran E; Gandin V; Bertani R; Sgarbossa P; Natarajan K; Bhuvanesh NSP; Venzo A; Zoleo A; Mozzon M; Dolmella A; Albinati A; Castellano C; Reis Conceição N; C Guedes da Silva MF; Marzano C
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structures, spectroscopy and antimicrobial properties of complexes of copper(II) with salicylaldehyde N-substituted thiosemicarbazones and 2,2'-bipyridine or 1,10-phenanthroline.
    Lobana TS; Indoria S; Jassal AK; Kaur H; Arora DS; Jasinski JP
    Eur J Med Chem; 2014 Apr; 76():145-54. PubMed ID: 24583354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, X-ray crystal structure, DNA binding, antioxidant and cytotoxicity studies of Ni(ii) and Pd(ii) thiosemicarbazone complexes.
    Ramachandran E; Kalaivani P; Prabhakaran R; Rath NP; Brinda S; Poornima P; Padma VV; Natarajan K
    Metallomics; 2012 Feb; 4(2):218-27. PubMed ID: 22101384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target.
    Carcelli M; Tegoni M; Bartoli J; Marzano C; Pelosi G; Salvalaio M; Rogolino D; Gandin V
    Eur J Med Chem; 2020 May; 194():112266. PubMed ID: 32248006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, spectroscopic, anticancer and antibacterial studies of Ni(II) and Cu(II) complexes with 2-carboxybenzaldehyde thiosemicarbazone.
    Chandra S; Vandana
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():333-8. PubMed ID: 24747857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents.
    Akladios FN; Andrew SD; Parkinson CJ
    Biometals; 2016 Oct; 29(5):789-805. PubMed ID: 27389037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.